Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,697
Total Claims
$3.5M
Drug Cost
1,124
Beneficiaries
$3,154
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
+270%
Opioid rate vs peers
4.8% vs 1.3% avg
-22%
Cost per patient vs peers
$3,154 vs $4,034 avg
-1%
Brand preference vs peers
9.3% vs 9.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 270% above Neurology peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
4.8%
Opioid Rate
421
Opioid Claims
$91K
Opioid Cost
8.3%
Long-Acting Rate
Brand vs Generic
Brand: 808 claims · $3.1M
Generic: 7,837 claims · $411K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Ofatumumab | 36 | $419K |
| Dimethyl Fumarate | 23 | $264K |
| Immune Globul G/Gly/Iga Avg 46 | 26 | $254K |
| Deutetrabenazine | 18 | $195K |
| Pimavanserin Tartrate | 27 | $136K |
| Valbenazine Tosylate | 13 | $106K |
| Interferon Beta-1a | 13 | $98K |
| Onabotulinumtoxina | 68 | $85K |
| Immun Globg(Igg)/Malt/Iga Ov50 | 12 | $80K |
| Erenumab-Aooe | 41 | $65K |
| Rimegepant Sulfate | 35 | $55K |
| Oxycodone Hcl | 27 | $50K |
| Dimethyl Fumarate | 41 | $48K |
| Eslicarbazepine Acetate | 14 | $38K |
| Levetiracetam | 15 | $36K |
Prescribing Profile
100
Unique Drugs
21.0
Anomaly Score
Patient Profile
69
Avg Age
58%
Female
1.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About